Wikidata

(Q63336838)

English

Metronomic and Targeted Anti-angiogenesis Therapy for Children With Recurrent/Progressive Medulloblastoma

clinical trial

In more languages

Statements

short name
MEMMAT (English)
0 references
title
A Phase II Study of Metronomic and Targeted Anti-angiogenesis Therapy for Children With Recurrent/Progressive Medulloblastoma (English)
0 references
country
Austria
0 references
Denmark
0 references
France
0 references
Sweden
0 references
main subject
child
0 references
start time
April 2014
0 references
end time
April 2021
0 references
number of participants
40
0 references
research intervention
bevacizumab
0 references
thalidomide
0 references
(RS)-cyclophosphamide
0 references
etoposide
0 references
etoposide phosphate
0 references
cytarabine
0 references
celecoxib
0 references
fenofibric acid
0 references
maximum age
19 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63336838&oldid=1883014292"